Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 310.00
Bid: 309.00
Ask: 310.00
Change: 10.00 (3.33%)
Spread: 1.00 (0.324%)
Open: 304.00
High: 316.00
Low: 304.00
Prev. Close: 300.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Thu, 23rd Jul 2020 16:03

Friday 24 July 
Nostra Terra Oil & Gas Co PLCAGM
Renold PLCAGM
Surface Transforms PLCAGM
Kingfisher PLCAGM
Arkle Resources PLCAGM
Bahamas Petroleum CoAGM
Ascent Resources PLCAGM
Remote Monitored Systems PLCAGM
Monday 27 July 
Tekcapital PLCAGM
Cambridge Cognition Holdings PLCAGM
National Grid PLCAGM
SpaceandPeople PLCAGM
BMO UK High Income Trust PLCAGM
Draper Esprit PLCAGM
Tuesday 28 July 
TR Property Investment Trust PLCAGM
Wizz Air Holdings PLCAGM
ULS Technology PLCAGM
1Spatial PLCAGM
Codemasters Group Holdings PLCAGM
Inspired Energy PLCGM re placing and open offer
Vodafone Group PLCAGM
JPMorgan Japan Smaller Companies Trust PLCAGM
Mitie Group PLCAGM
Wednesday 29 July 
Drax Group PLCHalf Year Results
Caspian Sunrise PLCAGM
Baron Oil PLCAGM
WANdisco PLCAGM
British Land Co PLCAGM
Water Intelligence PLCAGM
Walker Greenbank PLCAGM
Rose Petroleum PLCAGM
Urban Exposure PLCAGM
Aminex PLCAGM
Equals Group PLCAGM
Ferguson PLCGM (re approval of additional listing on a major US stock exchange)
Caledonia Investments PLCAGM
Hibernia REIT PLCAGM
Thursday 30 July 
TMT Investments PLCAGM
Iofina PLCAGM
Angling Direct PLCAGM
Card Factory PLCAGM
Highland Gold Mining LtdAGM
BMO Global Smaller Companies PLCAGM
Hutchison China MediTech LtdAGM
Ukrproduct Group LtdAGM
Stobart Group LtdAGM
London & Associated Properties PLCAGM
Volex PLCAGM
OnTheMarket PLCAGM
Norcros PLCAGM
CMC Markets PLCAGM
Gabelli Value Plus+ Trust PLCAGM
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2021 21:59

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug

Read more
29 Sep 2021 11:08

Hutchmed China sells joint venture stake for USD169 million

Hutchmed China sells joint venture stake for USD169 million

Read more
21 Sep 2021 10:51

Hutchmed starts drug combination trial for neuroendocrine tumours

Hutchmed starts drug combination trial for neuroendocrine tumours

Read more
20 Sep 2021 09:09

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors

Read more
13 Sep 2021 10:22

Hutchmed China's amdizalisib secures breakthrough therapy designation

Hutchmed China's amdizalisib secures breakthrough therapy designation

Read more
8 Sep 2021 13:49

Hutchmed, Astra launch drug combination trial to treat lung cancer

Hutchmed, Astra launch drug combination trial to treat lung cancer

Read more
6 Sep 2021 09:37

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

Read more
26 Aug 2021 10:38

Hutchmed launches trial into drug combination to treat breast cancer

Hutchmed launches trial into drug combination to treat breast cancer

Read more
9 Aug 2021 12:35

Hutchmed strikes collaboration deal with Epizyme

(Sharecast News) - Commercial-stage biotechnology company Hutchmed China announced a collaboration to research, develop, manufacture and commercialise 'Tazverik' in Greater China on Monday, including mainland China, Hong Kong, Macau and Taiwan.

Read more
9 Aug 2021 10:06

Hutchmed to partner with Epizyme on tumour-targetting treatment

Hutchmed to partner with Epizyme on tumour-targetting treatment

Read more
28 Jul 2021 14:51

Hutchmed research costs deepen loss; expects US launches in 2022, 2023

Hutchmed research costs deepen loss; expects US launches in 2022, 2023

Read more
28 Jul 2021 11:33

IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial

IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial

Read more
28 Jul 2021 10:58

AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%

AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%

Read more
21 Jul 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
16 Jul 2021 11:19

AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks

AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.